|
1 |
GW Pharmaceuticals
Licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. GW’s lead product, Sativex®, has been approved by various countries including UK.
|
225 |
|
2 |
Pharmos corporation
Manufacturers of Dexanabinol (synthetic cannabinoid). Expertise in the discovery and development of synthetic cannabinoid compounds
|
154 |
|
3 |
British Medical Association
Info and reports
|
159 |
|
4 |
Multiple Sclerosis Society (UK)
Supports people whose lives are affected by multiple sclerosis by funding research and providing local and national services.
|
137 |
|
5 |
The Royal Pharmaceutical Society of Great Britain
Acts as the registration and professional body for pharmacists in all aspects of practice. Soon to undertake clinical trials of cannabis derivatives.
|
144 |
|
6 |
National Multiple Sclerosis Society (US)
US based MS society
|
127 |
|
7 |
Disability Now
Newspaper, searchable website, conducted survey of disabled people finding 67% had used cannabis for medicinal purposes and 98% favoured a change in the law.
|
164 |
|
8 |
The Science of Medical Marijuana
Medical marijuana research is something of a "forgotten history" in the United States. This site illustrates the fact that much promising research was once conducted on marijuana.
|
139 |
Medicinal Cannabis